Clinical management of psoriasis patients during the COVID-19 pandemic

Abstract

Psoriasis is a systemic immune-mediated inflammatory disease that requires consistent treatment and follow-up. Given that COVID-19 will persist in the coming years, dermatologists need to adjust their practices accordingly to care for their patients, particularly psoriasis patients managed with systemic therapies. We provide guidelines for optimizing care for psoriasis patients, including considerations for medication management, lifestyle adjustments, and utilization of telemedicine.

Keywords

• psoriasis
• biologics
• biological products/therapeutic use
• dermatologic agents/therapeutic use
• covid-19
• coronavirus
• pandemic
• management
• telemedicine